Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739389 | PMC |
| http://dx.doi.org/10.1186/s13063-016-1195-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Author Correction: Layer-by-layer phase transformation in TiO revealed by machine-learning molecular dynamics simulations.
Nat Commun
January 2025
Shenyang National Laboratory for Materials Science, Institute of Metal Research, Chinese Academy of Sciences, Shenyang, 110016, China.
Corrigendum to "Bovine serum albumin-liposome stabilized high oil-phase emulsion: Effect of liposome ratio on interface properties and stability" [Int. J. Biol. Macromol. 266 (2024) 131040].
Int J Biol Macromol
January 2025
School of Food Science and Engineering, Hainan University, Haikou 570228, China; College of Food Science and Technology, Hainan Tropical Ocean University, Sanya 572022, China. Electronic address:
Corrigendum to "A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1)" [Vaccine 41 (2023) 3387-3398].
Vaccine
January 2025
MSD (UK) Limited, London, United Kingdom.
ADAM10 modulates the efficacy of T-cell mediated therapy in solid tumors.
Immunol Cell Biol
January 2025
Department of Vascular Surgery, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and PekingUnion Medical College, Beijing, China.
Correction: Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) Study.
Dermatol Ther (Heidelb)
January 2025
Institute and Comprehensive Center Inflammation Medicine, University of Lübeck, Lübeck, Germany.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!